Proceedings of the Third Annual Interactive Genitourinary Cancer Conference, 30 April-1 May 2011, Budapest, HungaryFITZPATRICK, John M.BJU international. Supplement (Print). 2012, Vol 109, Num 2, issn 1465-5101, 23 p.Conference Proceedings

Surgery Illustrated : Surgical Atlas Millin Retropubic ProstatectomyFITZPATRICK, John M.BJU international (Papier). 2008, Vol 102, Num 7, pp 906-916, issn 1464-4096, 11 p.Article

Optimising repeat prostate biopsy decisions and proceduresKIRBY, Roger; FITZPATRICK, John M.BJU international (Papier). 2012, Vol 109, Num 12, pp 1750-1754, issn 1464-4096, 5 p.Article

Management of localized prostate cancer in senior adults : the crucial role of comorbidityFITZPATRICK, John M.BJU international. Supplement (Print). 2008, Vol 101, Num 2, pp 16-22, issn 1465-5101, 7 p.Article

The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasiaFITZPATRICK, John M; DESGRANDCHAMPS, Francois.BJU international (Papier). 2005, Vol 95, Num 4, pp 575-579, issn 1464-4096, 5 p.Article

Taxane Mechanisms of Action: Potential Implications for Treatment Sequencing in Metastatic Castration-resistant Prostate CancerFITZPATRICK, John M; DE WIT, Ronald.European urology. 2014, Vol 65, Num 6, pp 1198-1204, issn 0302-2838, 7 p.Article

Risk stratification for benign prostatic hyperplasia (BPH) treatmentEMBERTON, Mark; FITZPATRICK, John M; REES, Jon et al.BJU international (Papier). 2011, Vol 107, Num 6, pp 876-880, issn 1464-4096, 5 p.Article

Medical treatment of benign prostatic hyperplasiaCONNOLLY, Stephen S; FITZPATRICK, John M.Postgraduate medical journal. 2007, Vol 83, Num 976, pp 73-78, issn 0032-5473, 6 p.Article

Side-effects of treatments for locally advanced prostate cancerO'CONNOR, Kevin M; FITZPATRICK, John M.BJU international (Papier). 2006, Vol 97, Num 1, pp 22-28, issn 1464-4096, 7 p.Article

Prostate cancer diagnosis in the new millennium : strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3)KIRBY, Roger S; FITZPATRICK, John M; IRANI, Jacques et al.BJU international (Papier). 2009, Vol 103, Num 4, pp 441-445, issn 1464-4096, 5 p.Article

The natural history of benign prostatic hyperplasiaFITZPATRICK, John M.BJU international (Papier). 2006, Vol 97, pp 3-6, issn 1464-4096, 4 p., SUP2Article

Is hormone ablation still the right choice for advanced prostate cancer?FITZPATRICK, John M.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 36-39, issn 1465-5101, 4 p.Article

Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC)SARTOR, A. Oliver; FITZPATRICK, John M.BJU international (Papier). 2012, Vol 110, Num 3, pp 328-335, issn 1464-4096, 8 p.Article

Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaROSEN, Raymond C; FITZPATRICK, John M.BJU international (Papier). 2009, Vol 104, Num 7, pp 974-983, issn 1464-4096, 10 p.Article

Testicular CancerSTERNBERG, Cora N; SHEINFELD, Joel; FITZPATRICK, John M et al.BJU international (Papier). 2009, Vol 104, Num 9, issn 1464-4096, 97 p., bSerial Issue

The natural history of benign prostatic hyperplasiaFITZPATRICK, John M.BJU international. Supplement (Print). 2006, Vol 97, Num 2, pp 3-6, issn 1465-5101, 4 p.Article

Experiences in advanced and metastatic prostate cancerFITZPATRICK, John M; NEWLING, Don; VELA-NAVARRETE, Remigio et al.European urology. Supplement. 2002, Vol 1, Num 7, pp 39-43, issn 1569-9056, 5 p.Article

The role of ethical publishing in promoting the evidence-based practice of urology : Evicence-based medicine in urologySHARROCK, Gavin; GRAF, Chris; FITZPATRICK, John M et al.World journal of urology (Print). 2011, Vol 29, Num 3, pp 319-324, issn 0724-4983, 6 p.Article

Prostate-specific antigen kinetics in localized and advanced prostate cancerFITZPATRICK, John M; BANU, Eugeniu; OUDARD, Stephane et al.BJU international (Papier). 2009, Vol 103, Num 5, pp 578-587, issn 1464-4096, 10 p.Article

Abarelix and other gonadotrophin―releasing hormone antagonists in prostate cancerKIRBY, Roger S; FITZPATRICK, John M; CLARKE, Noel et al.BJU international (Papier). 2009, Vol 104, Num 11, pp 1580-1584, issn 1464-4096, 5 p.Article

Therapeutic strategies for managing BPH progressionFITZPATRICK, John M; ARTIBANI, Walter.European urology. Supplement. 2006, Vol 5, Num 20, pp 997-1003, issn 1569-9056, 7 p.Article

The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasiaGERBER, Glenn S; FITZPATRICK, John M.BJU international (Papier). 2004, Vol 94, Num 3, pp 338-344, issn 1464-4096, 7 p.Article

PSA: Promoter of stress and anxiety or providentially-sent antigen?FITZPATRICK, John M; BLACKLEDGE, George; NEWLING, Don et al.European urology. Supplement. 2002, Vol 1, Num 7, pp 10-14, issn 1569-9056, 5 p.Article

Practical aspects of metastatic castration-resistant prostate cancer management: patient case studiesBAHL, Amit; BELLMUNT, Joaquim; OUDARD, Stéphane et al.BJU international. Supplement (Print). 2012, Vol 109, Num 2, pp 14-19, issn 1465-5101, 6 p.Conference Paper

Heat shock proteins: Their role in urological tumorsLEBRET, Thierry; WATSON, R. William G; FITZPATRICK, John M et al.The Journal of urology. 2003, Vol 169, Num 1, pp 338-346, issn 0022-5347, 9 p.Article